Financial reports
10-Q
2023 Q3
Quarterly report
6 Nov 23
ARS
2022 FY
Annual report to shareholders
2 Nov 23
10-Q
2023 Q2
Quarterly report
13 Sep 23
10-Q
2023 Q1
Quarterly report
8 Jun 23
10-K
2022 FY
Annual report
22 May 23
NT 10-Q
Notice of late quarterly filing
16 May 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
Current reports
8-K
Submission of Matters to a Vote of Security Holders
16 Jan 24
8-K
Amendments to Articles of Incorporation or Bylaws
18 Dec 23
8-K
Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results
3 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7 Sep 23
8-K
Termination of a Material Definitive Agreement
25 Aug 23
8-K
Departure of Directors or Certain Officers
9 Aug 23
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
20 Jul 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
17 Jul 23
8-K
Changes in Registrant's Certifying Accountant
22 Jun 23
8-K
Aridis Pharmaceuticals Announces First Quarter 2023 Financial Results and Business Update
8 Jun 23
Registration and prospectus
25-NSE
Exchange delisting
8 Sep 23
424B5
Prospectus supplement for primary offering
4 Aug 23
424B5
Prospectus supplement for primary offering
4 Aug 23
424B5
Prospectus supplement for primary offering
3 Aug 23
S-1/A
IPO registration (amended)
28 Jul 23
S-1/A
IPO registration (amended)
26 Jul 23
S-1/A
IPO registration (amended)
21 Jul 23
S-1/A
IPO registration (amended)
17 Jul 23
S-1/A
IPO registration (amended)
17 Jul 23
S-1/A
IPO registration (amended)
27 Jun 23
Proxies
DEFA14A
Additional proxy soliciting materials
18 Dec 23
DEFA14A
Additional proxy soliciting materials
15 Dec 23
DEFA14A
Additional proxy soliciting materials
3 Nov 23
DEF 14A
Definitive proxy
2 Nov 23
DEFA14A
Additional proxy soliciting materials
19 Apr 22
DEF 14A
Definitive proxy
18 Apr 22
DEF 14A
Definitive proxy
16 Apr 21
DEF 14A
Definitive proxy
17 Apr 20
DEF 14A
Definitive proxy
2 Jul 19
Other
EFFECT
Notice of effectiveness
2 Aug 23
CORRESP
Correspondence with SEC
31 Jul 23
CORRESP
Correspondence with SEC
20 Jul 23
CORRESP
Correspondence with SEC
17 Jul 23
CORRESP
Correspondence with SEC
27 Jun 23
UPLOAD
Letter from SEC
15 Jun 23
UPLOAD
Letter from SEC
31 May 23
EFFECT
Notice of effectiveness
15 Dec 22
UPLOAD
Letter from SEC
12 Dec 22
CORRESP
Correspondence with SEC
12 Dec 22
Ownership
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13G/A
Lind Global Fund II LP
13 Feb 24
4
JOHN F HAMILTON
19 Sep 23
4
Susan Richards Windham-Bannister
19 Sep 23
4
Eric Patzer
19 Sep 23
4
Vu Truong
19 Sep 23
4
Hasan Jafri
19 Sep 23
4
Eric Patzer
15 Jun 23
4
JOHN F HAMILTON
15 Jun 23
4
Vu Truong
15 Jun 23